Psychedelics-Focused Numinus Plans To Leverage This AI Technology Via New Strategic Acquisition
Psychedelics-focused mental healthcare company Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23) plans to take over MedBright AI Investments Inc. (CSE: MBA).The proposed transaction comes as the Vancouver-based company reorganizes its operations with a near-term strategic plan toward generating positive EBITDA.Numinus announced on Thursday the execution of a letter of intent to acquire MedBright which deploys artificial intelligence and machine learning to allow medical professionals to deliver increased access to healthcare, reduce healthcare costs, and improve patient outcomes, by way of a statutory plan of arrangement.
